World Pharma News

Trump bans export of coronavirus protection gear, says he’s ‘not happy with 3M’

Trump bans export of coronavirus protection gear, says he’s ‘not happy with 3M’

President Donald Trump on Friday invoked the Defense Production Act to ban “unscrupulous actors and profiteers” from exporting critical medical gear used to protect wearers from the coronavirus.

The president unveiled the new order amid a dispute with U.S. manufacturing giant 3M, which had warned the Trump administration that halting its exports of respirator masks could make them even less available in the United States.

“We’re not happy with 3M. We’re not at all happy with 3M. And the people who dealt with it directly are not happy with 3M,” Trump said at a White House press briefing Friday evening.
Under the new order, acting Homeland Security Secretary Chad Wolf will work with FEMA to “prevent the export of N-95 respirators, surgical masks, gloves and other personal protective equipment,” Trump said.

“We need these items immediately for domestic use, we have to have ’em,” the president added.

The White House released details of the order after the press conference, which in part states, “To ensure that these scarce or threatened PPE materials remain in the United States for use in responding to the spread of COVID-19, it is the policy of the United States to prevent domestic brokers, distributors, and other intermediaries from diverting such material overseas.”

“Nothing in this order will interfere with the ability of PPE manufacturers to export when doing so is consistent with United States policy and in the national interest of the United States,” a statement from Trump said.

Trump had first attacked 3M on Thursday, after approving an order for Wolf to “use any and all authority” to acquire as many respirators from the company or its affiliates as was deemed “appropriate.”

“We hit 3M hard today,” Trump tweeted later that night, “after seeing what they were doing with their Masks.”

 

“Big surprise to many in government as to what they were doing – will have a big price to pay!” Trump wrote.

 

 

 
 

 

In a CNBC interview Friday morning, 3M CEO Mike Roman pushed back on Trump’s scathing tweet, saying it was “absurd” to suggest his company wasn’t doing all it could to help the U.S. fight the pandemic.

“The idea that we’re not doing everything we can to maximize deliveries of respirators in our home country – nothing is further from the truth,” Roman said. The company said in a response to the president’s executive order that the Trump administration “requested that 3M cease exporting respirators that we currently manufacture in the United States to the Canadian and Latin American markets.”

But “there are, however, significant humanitarian implications of ceasing respirator supplies” to health care workers in those countries, where 3M is a “critical supplier of respirators,” 3M’s statement said.

“In addition, ceasing all export of respirators produced in the United States would likely cause other countries to retaliate and do the same, as some have already done,” the company said.

The Financial Times reported that the White House tried to force 3M to export N95 masks from its Singapore facilities to the U.S. rather than sending them to its markets in Asia.

 thumb large

The news outlet also reported Friday that the U.S. had intercepted 3M masks that were headed for Germany.

But 3M said in a statement Friday night that it “has no evidence to suggest 3M products have been seized.”

“3M has no record of any order of respirators from China for the Berlin police. We cannot speculate where this report originated,” the company said.

Neither the White House nor the National Security Council provided comment to CNBC on the Financial Times’ report. 

donalt tramp

Full statement from President Donald Trump regarding the Defense Production Act

America is at war against an invisible enemy.  Unfortunately, the outbreak of the virus has led to wartime profiteering by unscrupulous brokers, distributors, and other intermediaries operating in secondary markets.  This wartime profiteering is leading to hoarding and soaring prices for Personal Protective Equipment (PPE) like masks, gloves, and N-95 respirators, all of which are needed to protect American citizens, including our heroic healthcare professionals, battling on the front lines.

The ability of wartime profiteers to purchase domestic supplies of scarce and critical materials, hoard them while they engage in profiteering and speculation, and then export them can generate foreign demand, and lead to price gouging.  This conduct denies our country and our people the materials they need to win the war against the virus.  

Wartime profiteers may include a large army of speculators and warehouse operators operating in the dark corners of our markets.  They may also include some well-established PPE distributors with the ability to unscrupulously divert PPE inventories from domestic customers, such as hospitals and State governments, to foreign purchasers willing to pay significant premiums.

Today’s order is another step in our ongoing fight to prevent hoarding, price gouging, and profiteering by preventing the harmful export of critically needed PPE.  It will help ensure that needed PPE is kept in our country and gets to where it is needed to defeat the virus.  

Nothing in this order will interfere with the ability of PPE manufacturers to export when doing so is consistent with United States policy and in the national interest of the United States.

Διαβάστε όλες τις τελευταίες Ειδήσεις για την υγεία από την Ελλάδα και τον Κόσμο

Διαβάστε Eπίσης:

Hardo Fischer exclusively on healthweb: Gene therapies introduce new therapeutic model in Medicine

‘AeroNabs’ promise powerful, inhalable protection against COVID-19

The Health Economy: A Strengthening and Stabilizing factor for Economic Development

Dr. Emmanuel Alexandrakis is a Global Market Strategist at the WifOR Institute, a German independent Economic Research Organization, and Adjunct Professor at the MBA International Program of the Athens University of Economics and Business for Health Sector Strategy. The recent global crisis, that was triggered by the COVID-19 pandemic, underlined the importance of investing in the health sector. The unprecedented effects of this global pandemic, […]

How risky is it to attend a Trump campaign rally during a pandemic?

As the coronavirus plows through the United States, health experts worry President Donald Trump’s campaign rally in Tulsa, Oklahoma, will become a new hotspot for coronavirus infections. Leaders and public health experts have expressed concern, including Dr. Anthony Fauci, the nation’s top infectious disease expert, as well as Bruce Dart, the director of Tulsa’s health […]

Trump officials deflect blame for US death toll, escalate reopening push

Analysis by Stephen Collinson, CNN N)Two of President Donald Trump’s top officials are now pointing the finger at the administration’s own scientists and Americans’ pre-existing health conditions to explain the country’s world-leading Covid-19 death toll. Health and Human Services Secretary Alex Azar suggested Sunday that underlying health conditions, including among minorities, were one reason for the high American […]

Coronavirus Q&As for Consumers

The FDA is working to address the coronavirus disease (COVID-19) outbreak and keep you and your family informed on the latest developments. Here are answers to some frequently asked questions from consumers about treatments and prevention:   Q: Are antibiotics effective in preventing or treating COVID-19?   A: No. Antibiotics do not work against viruses; […]

WHO warns of global medical equipment shortage as world braces for coronavirus spread

Countries worldwide are preparing for the possibility of public health emergencies related to the novel coronavirus, as the World Health Organization warned a shortage of protective equipment is hampering the response to the outbreak. The virus has infected more than 92,800 people and killed at least 3,200 since it was first identified in the Chinese […]

Scottish Academy launches ‘bold’ strategic priorities

by Anna Smith The Academy of Medical Royal Colleges and Faculties in Scotland (the Scottish Academy) has published its strategic priorities to 2023, outlining a focus on collaborative working between the different medical professions in Scotland, to “improve quality of care for patients.” The Academy, which promotes and co-ordinates the work of the Medical Royal Colleges […]

MHRA updates Dysport license to include upper limb spasticity in children

By Anna Smith The Medicines and Healthcare Products Regulatory Agency (MHRA) has granted Ipsen a licence update for Dysport (abobotulinumtoxinA), extending the use of the drug to focal spasticity of upper limbs in paediatric cerebral palsy (CP) patients, two years of age or older. The regulatory body says that the approval was based on a […]

More prescription ranitidine recalled from shelves

By Anna Smith The Medicines and Healthcare Regulatory Agency (MHRA) has issued a drug alert, as Creo Pharma Limited and Tillomed Laboratories have recalled their unexpired stock of prescription-only ranitidine. GSK’s formulation of the drug, called Zantac and used for heartburn and stomach ulcers, was recalled in the USA last month after the US Food and […]